Semaglutide has long been demonstrated to cause medullary thyroid cell carcinoma in rodents. Though its medical relevance to humans is unknown, the FDA advises to not administer this drug in Those people with a personal or family historical past of medullary thyroid carcinoma. Semaglutide also poses a hazard of pancreatitis and dehydration.Semaglut